GE HealthCare Technologies Inc. 8K

GE HealthCare announced a CFO transition with George Newcomb named interim CFO and reaffirmed its full-year 2026 outlook alongside stronger-than-expected preliminary Q2 2026 results.

On July 23, 2026, GE HealthCare Technologies Inc. announced that its Chief Financial Officer, James (Jay) Saccaro, will step down from his role to pursue an expanded opportunity outside the medical technology industry, with current Controller and Chief Accounting Officer George Newcomb appointed as interim CFO and Saccaro remaining through August 14, 2026 to ensure an orderly transition, while simultaneously providing preliminary, unaudited second quarter 2026 results indicating 5.7% year-over-year revenue growth, 3.5% organic revenue growth, diluted and adjusted EPS above prior expectations, and reaffirming its full-year 2026 financial guidance on the back of strong orders, healthy demand, and continued commercial execution.

Filing Facts

CIK

1932393

Ticker

GEHC

Form

8K

Source Type

sec

Accession

0001932393-26-000039

Alert Tier

7